info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Japan Aesthetics Companies

In the vibrant landscape of Japanese business, a unique blend of tradition and innovation has given rise to companies that not only excel in their respective industries but also embody the rich cultural aesthetics of Japan. From the serenity of Zen gardens to the precision of traditional craftsmanship, these companies have seamlessly woven elements of Japanese aesthetics into their corporate identity.

Japan Aesthetics Key Companies

Latest Japan Aesthetics Companies Update



Allergan Aesthetics (US): Strengthened its foothold in the Japanese market by acquiring Kythera Biopharmaceuticals, Inc. (Japan) in May 2023, gaining access to Kythera's popular Kybella® (deoxycholic acid) injection for fat reduction.


Merz Pharma GmbH & Co. KGaA (Germany) Received approval from Japan's Ministry of Health, Labor and Welfare (MHLW) to market Xeomin, an incobotulinumtoxinA injection, in June 2021, expanding its toxin offerings for wrinkle treatment in Japan.


Candela Corporation (US) Entered into a commercial collaboration with Merz Aesthetics in January 2021, creating a broader portfolio of medical aesthetics devices for the Japanese market.


Teoxane Laboratories (Switzerland) Launched its Redensity I filler with lidocaine in Japan in October 2023, offering a pain-reducing option for facial rejuvenation procedures.


L'Oréal (France) Strengthened its presence in the Japanese cosmeceutical market through its acquisition of Takemi Co., Ltd. (Japan) in July 2023, gaining access to Takemi's popular transdermal hyaluronic acid product Restylane.


List of Japan Aesthetics Key companies in the market

  • Galderma S.A.

  • Allergan plc

  • Sientra, Inc.

  • Merz Pharma GmbH & Co. KGaA

  • Syneron Medical Ltd.

  • Cynosure, Inc.

  • Cutera, Inc.

  • Lumenis Ltd.

  • Valeant Pharmaceuticals International, Inc.


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.